TABLE 4.
Comparison of changes in mean total score of SF-36 questionnaire between the groups.
Duration (Days) | Mean total score of SF-36 questionnaire ( ± SD) | p value | |
---|---|---|---|
Uthever (N = 31) | Placebo (N = 31) | ||
Baseline | 132.77 ± 8.91 | 129.64 ± 17.04 | 0.37 |
30 | 138.15 ± 7.45 | 134.52 ± 14.48 | — |
60 | 141.36 ± 8.62 | 134.04 ± 18.06 | — |
Mean diff (Baseline–Day 30) (p value) | *5.38 ± 08.94 (0.00) | *4.88 ± 07.83 (0.00) | 0.82 |
Mean diff (Baseline–Day 60) (p value) | *8.59 ± 11.83 (0.00) | *4.40 ± 16.06 (0.13) | 0.25 |
By Wilcoxon Sign Rank Test p > 0.05 was considered not significant.
By Mann Whitney U Test.